EZH2 and thoracic aortic aneurysm: Recently, Lino Cardenas et al., reported that EZH2 inhibitor treatment reduced the expansion of thoracic aortic aneurysms in Fbn1(C1039G/+) mice, referred to as Marfan mice, by improving the cytoskeletal architecture, along with restoring the SM22α expression [56].